GKB Ophthalmics

GKBOPHTHALMICS29 Jan 2015

FMCG

₹

0.00 (0.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in GKB Ophthalmics

GKB Ophthalmics

FMCG

GKBOPHTHALMICS29 Jan 2015

₹

0.00 (0.00%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
31-Aug-2010	D	GKB Ophthalmics Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 31, 2010, inter alia, have recommended a dividend of Rs. 1.20 per equity share.	21-Sep-2010
25-Apr-2024	BC	GKB OPHTHALMICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve the audited standalone and consolidated fi	30-May-2024
11-Aug-2023	BC	The meeting of the Board of Directors of the Company was held on August 11, 2023, which considered and took on record the Unaudited Standalone and Consolidated Financial Results of the Company for th	01-Apr-2024
30-Mar-2024	BC	K.G. Gupta	27-Mar-2024
19-Mar-2024	BC	A separate meeting of the Independent Directors of the Company for the year 2023-24 was held pursuant to Regulation 25(3) of SEBI ( Listing Obligations and Disclosure Requirements ) Regulations, 2015	19-Mar-2024
19-Mar-2024	BC	Pursuant to Regulation 30 of the Securities and Exchange Board of India ( Listing Obligations and Disclosure Requirements) Regulations, 2015 enclosed please find the disclosure pertaining to the resi	16-Mar-2024

No Rights has been declared by GKBOPHTHALMICS

Book Closure

Record Date	Split Date	Purpose
30-May-2024	-	GKB OPHTHALMICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve the audited standalone and consolidated fi
01-Apr-2024	-	The meeting of the Board of Directors of the Company was held on August 11, 2023, which considered and took on record the Unaudited Standalone and Consolidated Financial Results of the Company for th
27-Mar-2024	-	K.G. Gupta
19-Mar-2024	-	A separate meeting of the Independent Directors of the Company for the year 2023-24 was held pursuant to Regulation 25(3) of SEBI ( Listing Obligations and Disclosure Requirements ) Regulations, 2015
16-Mar-2024	-	Pursuant to Regulation 30 of the Securities and Exchange Board of India ( Listing Obligations and Disclosure Requirements) Regulations, 2015 enclosed please find the disclosure pertaining to the resi

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
GKB Ophthalmics Ltd ₹84.05(0.00/0.00%)	84.05	+0.00	42.37	173.78	0.00	2.39
Vadilal Industries Ltd ₹4,768.35(+262.40/5.82%)	4,768.35	+262.40	3,239.78	125.04	34.35	11.14
Hatsun Agro Product Ltd ₹1,098.10(-3.20/-0.29%)	1,098.10	-3.20	24,531.27	23.91	91.75	15.60
Agro Tech Foods Ltd ₹755.45(-0.30/-0.04%)	755.45	-0.30	1,841.76	-3.39	240.05	3.69
Dabur India Ltd ₹509.20(+1.45/0.29%)	509.20	+1.45	89,975.29	-5.35	60.71	13.52
Hindustan Unilever Ltd ₹2,237.95(+7.50/0.34%)	2,237.95	+7.50	524,064.58	-9.02	51.48	10.28

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	6.84	7.27	9.71	6.47	6.53	7.05
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	6.84	7.27	9.71	6.47	6.53	7.05
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	1.72	0.07	0.09	0.26	1.70	0.02
Total Income	8.56	7.34	9.80	6.73	8.23	7.07
Total Expenditure	7.85	8.12	8.72	6.98	7.55	7.25
PBIDT	0.71	-0.78	1.08	-0.25	0.68	-0.18
Interest	0.36	0.38	0.37	0.40	0.34	0.41
PBDT	0.35	-1.16	0.71	-0.65	0.34	-0.59
Depreciation	0.66	0.65	0.64	1.55	0.32	0.32
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	-0.09	-0.03	-0.02
Reported Profit After Tax	-0.31	-1.81	0.08	-2.12	0.05	-0.89
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-0.31	-1.81	0.08	-2.12	0.05	-0.89

EPS (Unit Curr.)	-0.61	-3.59	0.15	-4.20	0.10	-1.76
EPS (Adj) (Unit Curr.)	-0.61	-3.59	0.15	-4.20	0.10	-1.76
Calculated EPS (Unit Curr.)	-0.61	-3.59	0.15	-4.20	0.10	-1.76
Calculated EPS (Adj) (Unit Curr.)	-0.61	-3.59	0.15	-4.20	0.10	-1.76
Calculated EPS (Ann.) (Unit Curr.)	-2.46	-14.36	0.60	-16.78	0.38	-7.03
Calculated EPS (Adj) (Ann.) (Unit Curr.)	-2.46	-14.36	0.60	-16.78	0.38	-7.03
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	5.04	5.04	5.04	5.04	5.04	5.04
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	10.38	-10.73	11.12	-3.86	10.41	-2.55
PBDTM(%)	5.12	-15.96	7.31	-10.05	5.21	-8.37
PATM(%)	-4.53	-24.90	0.82	-32.77	0.77	-12.62

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	24.04	20.40	22.26	19.96	19.11	18.56
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	24.04	20.40	22.26	19.96	19.11	18.56
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.35	0.31	0.35	0.23	-0.03	0.37
Total Income	24.38	20.71	22.61	20.19	19.09	18.94
Total Expenditure	24.52	20.70	20.90	20.35	19.18	17.02
PBIDT	-0.14	0.01	1.71	-0.16	-0.10	1.91
Interest	0.44	0.46	0.43	0.43	0.40	0.46
PBDT	-0.58	-0.44	1.27	-0.59	-0.50	1.45
Depreciation	0.73	0.73	0.72	1.63	0.40	0.39
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	0.00	0.00	0.00	-0.02	0.20	0.00
Deferred Tax	0.00	0.00	0.00	-0.09	-0.03	-0.02
Reported Profit After Tax	-1.31	-1.17	0.55	-2.12	-1.06	1.08
Minority Interest After NP	-0.19	-0.02	0.02	-0.16	-0.08	0.26
Net Profit after Minority Interest	-1.25	-1.17	0.52	-1.92	-1.03	0.85

Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-1.25	-1.17	0.52	-1.92	-1.03	0.85

EPS (Unit Curr.)	-2.48	-2.32	1.04	-3.80	-2.05	1.68
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	5.04	5.04	5.04	5.04	5.04	5.04

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	-0.58	0.05	7.68	-0.80	-0.52	10.29
PBDTM(%)	-2.41	-2.16	5.71	-2.96	-2.62	7.81
PATM(%)	-5.45	-5.74	2.47	-10.62	-5.55	5.82

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	5.04	5.04	5.04	5.04	4.64	4.15
Reserves Total	22.48	25.36	27.73	30.21	30.03	22.78
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	27.52	30.40	32.77	35.25	34.67	26.93
Secured Loans	11.22	11.75	11.32	10.04	10.05	9.93
Unsecured Loans	0.00	0.00	0.65	0.00	0.00	0.00
Total Debt	11.22	11.75	11.97	10.04	10.05	9.93
Total Liabilities	38.74	42.15	44.74	45.29	44.72	36.86
APPLICATION OF FUNDS :
Gross Block	41.58	43.17	42.35	49.22	45.25	34.76
Less : Accumulated Depreciation	24.30	21.90	20.07	24.39	20.96	17.79
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	17.28	21.27	22.28	24.83	24.29	16.97
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	3.82	3.29	1.23	0.00	0.00	0.24
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	11.90	11.90	12.22	3.21	0.32	0.66
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	6.06	5.34	6.98	4.70	6.79	14.84
Sundry Debtors	4.88	6.00	7.44	10.37	10.81	10.44
Cash and Bank	0.41	1.43	2.10	10.36	6.61	0.39
Loans and Advances	2.08	1.28	1.63	1.20	1.05	1.27
Total Current Assets	13.43	14.06	18.16	26.63	25.26	26.94
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	7.11	8.44	9.06	9.69	8.73	6.42
Provisions	0.43	0.39	1.07	0.47	0.51	0.52
Total Current Liabilities	7.53	8.83	10.14	10.16	9.24	6.94
Net Current Assets	5.89	5.23	8.03	16.48	16.02	20.00
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	2.01	0.00	1.68	1.71	0.45
Deferred Tax Liability	0.00	2.17	0.18	2.17	2.17	1.36
Net Deferred Tax	0.00	-0.16	-0.18	-0.49	-0.46	-0.91
Total Assets	38.90	41.53	43.58	44.03	40.17	36.97
Contingent Liabilities	16.39	17.32	19.78	19.78	29.87	18.87

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	5.04	5.04	5.04	5.04	4.64	4.15
Reserves Total	57.65	58.06	57.61	54.21	47.26	40.79
Equity Share Warrants	0.00	0.00	0.00	0.00	2.91	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	62.69	63.10	62.65	59.25	54.81	44.94
Minority Interest	4.60	4.32	3.65	0.00	0.00	0.00
Secured Loans	11.22	11.75	11.32	10.04	10.05	9.93
Unsecured Loans	0.00	0.00	0.65	5.12	4.02	0.00
Total Debt	11.22	11.75	11.97	15.16	14.07	9.93
Policy Holders Fund	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	2.53	2.27	1.22	1.13	1.03	0.71
Total Liabilities	81.04	81.44	79.49	75.54	69.91	55.58
APPLICATION OF FUNDS :
Gross Block	46.03	46.77	45.78	52.62	48.41	37.54
Less: Accumulated Depreciation	27.00	24.12	22.02	26.29	22.56	19.20
Less: Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	19.03	22.65	23.76	26.33	25.85	18.34
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	3.95	3.41	1.23	0.00	0.00	0.24
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	1.89	1.97	2.08	1.15	0.54	0.37
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	38.74	37.70	35.41	30.63	28.19	32.01
Sundry Debtors	27.74	19.51	19.48	24.92	23.54	27.46
Cash and Bank	14.45	16.40	17.28	13.87	10.04	2.55
Loans and Advances	2.60	1.92	1.51	3.54	2.61	1.44
Total Current Assets	83.53	75.53	73.68	72.95	64.38	63.46
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	30.62	28.16	26.07	25.75	22.56	25.77
Provisions	0.61	0.39	1.07	0.68	0.97	0.73
Total Current Liabilities	31.22	28.55	27.14	26.42	23.53	26.49
Net Current Assets	52.31	46.98	46.54	46.53	40.85	36.96
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	2.01	0.00	1.68	1.71	0.45
Deferred Tax Liability	0.00	2.17	0.18	2.17	2.17	1.36
Net Deferred Tax	0.00	-0.16	-0.18	-0.49	-0.46	-0.91
Other Assets	3.87	6.59	6.07	2.02	3.12	0.58
Total Assets
Contingent Liabilities	16.39	17.32	19.78	19.78	20.36	18.87

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.85	0.85	9.65	5.89	0.01
Net Cash from Operating Activities	-1.14	2.33	2.11	6.13	5.31
Net Cash Used In Investing Activities	2.40	-0.83	-11.52	-5.68	-8.63
Net Cash Used In Financing Activities	-2.03	-1.50	0.61	3.31	9.21
Net Inc./Dec In Cash And Cash Equivalents	-0.78	0.00	-8.80	3.76	5.88
Cash And Cash Equivalents At End Of The Year	0.07	0.85	0.85	9.65	5.89

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

50.93%

FII Shareholding

1.79%

DII Shareholding

0.01%

Public Shareholding

47.27%

**Promoter pledged shareholding 50.93%

About GKB Ophthalmics Ltd

GKB Ophthalmics Ltd is in the FMCG sector, having a market capitalization of Rs. 61.69 crores. It has reported a sales of Rs. 6.84 crores and a net profit of Rs. -0.31 crores for the quarter ended December 2018. The company management includes K G Gupta, K G Gupta,Vikram Gupta,Subhash Redkar,Anil Palekar,Shashi Kumar Katreddi,Purushottam Mantri (GKB Ophthalmics Ltd) among others.

Chairman

K G Gupta

Registered office

16-A,Tivim Industrial Estate,Mapusa,Goa,403526

FAX :91-832-2257044

Background

Incorporation Year1981

Face Value₹10

Market Lot1

How to buy GKB Ophthalmics shares on nse?

To buy GKB Ophthalmics shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the GKB Ophthalmics share price today?

The GKB Ophthalmics shares price on nse is Rs.84.05 today.

What is the market cap of GKB Ophthalmics shares on NSE ?

The company has a market capitalization of Rs.42.37Cr

What is the PE & PB ratio of GKB Ophthalmics shares ?

PE is 0 and PB is 2.39

What is the 52 Week High and Low of GKB Ophthalmics shares?

GKB Ophthalmics stock price high: Rs.90.9 GKB Ophthalmics stock price low: Rs.0